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Abstract
Background: The objective of this study was to develop models for predicting the evolution of a neck pain (NP)
episode.
Methods: Three thousand two hundred twenty-five acute and chronic patients seeking care for NP, were recruited
consecutively in 47 health care centers. Data on 37 variables were gathered, including gender, age, employment
status, duration of pain, intensity of NP and pain referred down to the arm (AP), disability, history of neck surgery,
diagnostic procedures undertaken, imaging findings, clinical diagnosis, and treatments used. Three separate
multivariable logistic regression models were developed for predicting a clinically relevant improvement in NP, AP
and disability at 3 months.
Results: Three thousand one (93.5%%) patients attended follow-up. For all the models calibration was good. The
area under the ROC curve was ≥0.717 for pain and 0.664 for disability. Factors associated with a better prognosis
were: a) For all the outcomes: pain being acute (vs. chronic) and having received neuro-reflexotherapy. b) For NP:
nonspecific pain (vs. pain caused by disc herniation or spinal stenosis), no signs of disc degeneration on imaging,
staying at work, and being female. c) For AP: nonspecific NP and no signs of disc degeneration on imaging. d) For
disability: staying at work and no signs of facet joint degeneration on imaging.
Conclusions: A prospective registry can be used for developing valid predictive models to quantify the odds that a
given patient with NP will experience a clinically relevant improvement.
Background
Neck pain (NP) is defined as pain in the neck with or
without pain referred into one or both upper limbs
(“arm pain” -AP-). Worldwide, the point prevalence of
NP is 4.9% (95% CI 4.6 to 5.3), and it is one of the top
five chronic pain conditions in terms of prevalence and
years lost to disability [1–3].
Most episodes of acute NP improve spontaneously,
but more than 30% of patients show some persistent or
recurrent symptoms 1 year later [3]. Early identification
of patients at higher risk of pain becoming chronic,
would help select those in whom more aggressive treat-
ments are worth considering. Therefore, the develop-
ment of prediction rules in this field has been
recommended as a research priority [4]. Unfortunately,
many of the existing prediction rules derive from studies
with small samples, or from re-analyses of data gathered
in experimental studies, which may produce results that
differ from those in routine practice [5].
Data from registries implemented in routine practice
could be useful to develop prediction rules factoring in
each patient’s personal and clinical characteristics, in-
cluding treatments received. This would also empower
patients for informed shared decision making [5].
Ideally, registries should include virtually all the pa-
tients, gather valid, reliable and clinically relevant data,
and ensure that losses to follow-up are kept to a mini-
mum. Concerns have been expressed with regard to the
feasibility of these requirements in routine clinical prac-
tice [6].
Therefore, the objectives of this study were; a) to ex-
plore the feasibility of implementing a registry of pa-
tients treated for NP in routine practice, b) use it to
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: fmkovacs@kovacs.org
1Unidad de la Espalda Kovacs, Hospital Universitario HLA-Moncloa. University
Hospital, Avenida de Menéndez Pelayo, 67, 28009 Madrid, Spain
2Spanish Back Pain Research Network, Madrid, Spain
Full list of author information is available at the end of the article
Kovacs et al. BMC Musculoskeletal Disorders          (2019) 20:620 
https://doi.org/10.1186/s12891-019-2962-9
develop predictive models in order to quantify the likeli-
hood that a given patient experiences a clinically rele-
vant improvement in NP, arm pain and disability, and c)
to assess such predictive models.
Methods
Setting
Forty-seven health care centers were selected by the
Spanish Back Pain Research Network to be invited to
participate in this study, based on their past involvement
in research on neck and low back pain. The centers were
located across 11 out of the 17 Administrative regions in
the country (Andalucía, Aragón, Asturias, Baleares,
Castilla-León, Cataluña, Extremadura, Galicia, Madrid,
Murcia, Vascongadas). The population of these regions
is 35,776,167, approximately 77% of the total population
of the country [7].
Fifteen centers belonged to the Spanish National
Health Service (SNHS), 6 to not-for-profit institutions
working for the SNHS, and 26 were private. They in-
cluded 8 primary care centers, 18 physical therapy prac-
tices, and 21 specialty Services in rheumatology (5),
rehabilitation (6), neuroreflexotherapy (4), and ortho-
pedic surgery (6).
Subjects
The inclusion and exclusion criteria were as follows.
Inclusion criteria: a) Seeking care for NP in a partici-
pating unit, b) suffering from neck pain, with or without
pain in the arm, unrelated to trauma or systemic disease,
and c) proficiency in Spanish.
Pain unrelated to systemic disease was defined as pain
unrelated to cancer or inflammatory disease (e.g., rheuma-
toid arthritis), in patients who did not present signs sug-
gesting fibromyalgia (defined as diffuse pain with
unexplained fatigue or sleep disturbances) or “red flags”
for latent systemic diseases. “Red flags” were defined as
“oncologic disease during the previous 5 years, constitu-
tional symptoms –unexplained weight loss, fever, chills-,
history of intravenous drug use, or immunocompromised
host” [8–11]. Patients with “red flags” could be included in
the study if the appropriate diagnostic test had ruled out
the presence of systemic diseases.
Patients who were included were asked to sign an in-
formed consent, authorizing the use of demographic and
clinical data related to their care for the purpose of this
study.
Exclusion criteria were: central nervous system disor-
ders (treated or untreated), other causes of referred or
radiated pain in the arm (e.g., peripheral nerve damage)
and not having signed the informed consent.
In order to analyze the influence of up to 40 variables,
the sample had to include at least 400 subjects who
would not experience improvement [12]. Approximately
80–85% of patients with spinal pain, experience a clinic-
ally relevant improvement in pain, referred pain and dis-
ability, at 3 months, while losses to follow-up at that
period range between 5 and 10% [13–16]. Therefore,
sample size was established at 2934 subjects. There were
no concerns about the sample size being too large, due
to the observational nature of the study.
Procedure
Since this study did not require any changes to standard
clinical practice, according to the Spanish law it was not
subject to approval by an Institutional Review Board. All
procedures followed were in accordance with the ethical
standards of the Helsinki Declaration of 1975, as revised
in 1983.
As per standard practice in Spain, patients and clinicians
received no compensation for participating in this study.
Patients were recruited consecutively at the participat-
ing centers. All patients seeking care for NP were
screened for inclusion and exclusion criteria.
All patients complying with inclusion criteria were
invited to participate, and all those who accepted to
sign the informed consent were included. Recruiting
clinicians explained to eligible patients the importance
of answering fully and accurately a series of question-
naires assessing their clinical status, and complying
with the follow-up visit for an assessment of their
evolution.
Patients were assessed upon recruitment and at follow-up.
The follow-up assessment was planned at 3months because:
a) this study sought to analyze the outcome of a single epi-
sode of neck pain rather than relapses, b) this timeframe im-
plies that all patients who are symptomatic at follow-up,
would be chronic [17]; c) existing studies conducted in the
environment where this study took place, have shown that
losses to follow-up remain minimal for periods of up to 3
months [15, 18, 19], rise at 6months [20–22], and become
increasingly significant thereafter [13, 23].
Patients were asked to complete the self-administered
questionnaires at both assessments. Questionnaires were
completed in private, with no interference from health
care personnel or any other actors. Data from the ques-
tionnaires were inserted into a database by a team of
auxiliary personnel with no connection to the treating
physician. In order to make clinical decisions, the treat-
ing clinicians had access to that information, but were
not able to alter the data. Participating in this study did
not imply any changes to patients’ clinical management,
and clinicians were instructed to manage their patients
as usual.
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Variables
This registry used the same variables and measuring in-
struments as the only registry of neck and back pain pa-
tients available in Spain. The latter was originally
developed for post-marketing surveillance of a minimally
invasive technology (“neuro-reflexotherapy”), and has
shown to be reliable and lead to low proportions of
missing data and losses to follow-up [14, 16, 24].
The registry gathered data from patients and from cli-
nicians. Data requested from patients at the first assess-
ment, were: gender, age (date of birth), duration of the
current pain episode (date of pain appearance), time
elapsed since the first episode (years), and employment
status (classified as working, on sick leave, receiving dis-
ability compensation, student, housewife, unemployed,
retired, or other; at the analysis phase, these categories
were collapsed into: “working”, “receiving financial com-
pensation for NP” -on sick leave or disabled for that rea-
son-, or “non worker” –any other status-).
At both assessments, patients were asked to report pain
and disability, which are considered two of the main out-
come measures for patients with spinal pain [25]. To this
end, they completed two separate 10-cm visual analog
scales for NP and AP (−VAS-, for which 0 = no pain and
10 = worst imaginable pain) [26], and a validated Spanish
version of the Neck Disability Index (−NDI-, for which
0 = no disability and 100 = worst possible disability) [18].
Data requested from recruiting clinicians were: diag-
nostic procedures prescribed for the current episode (X-
Rays, CT scan, MRI, EMG, other -blood analyses, scin-
tigraphy, etc.-), patients’ radiological findings on imaging
procedures performed for the current or previous epi-
sodes, as reported by radiologists (disc degeneration,
facet joint degeneration, scoliosis, difference in leg
length, spondylolisis, spinal stenosis, annular tear, disc
protrusion, disc herniation, other radiological findings,
no findings), diagnosis (pain caused by disc herniation,
spinal stenosis or “common non-specific NP”), and treat-
ments undergone by the patient throughout the study
(drugs –analgesics, NSAIDs, steroids, muscle relaxants,
opioids, other drugs-, physiotherapy and rehabilitation
-which were collapsed into a single category at the ana-
lysis phase, and were defined as any form of exercise,
heat, cold, electrotherapy or hands-on techniques, such
as massage or mobilization-, neuroreflexotherapy inter-
vention -defined as the implantation of surgical material
in specific areas of the skin, for up to 90 days- [27], sur-
gery, other treatments -e.g., spinal injections-).
Pain caused by disc herniation or spinal stenosis, was di-
agnosed if radicular pain or neurologic signs existed, and
were consistent with the location in which disc protru-
sion/herniation or spinal stenosis had been documented
on MRI. Patients not fitting into these definitions, were
classified as suffering from “common, non-specific NP”.
Analysis
All the analyses were undertaken by a team of independ-
ent biostatisticians who had no contact or communica-
tion with the clinicians involved in this study.
For categorical variables, absolute and relative frequen-
cies were calculated. When distribution was normal,
values for continuous variables were described through
their mean and standard deviation (SD). When their dis-
tribution departed from normality, median and percen-
tiles 25 and 75 were used.
Reductions in VAS or NDI scores between the base-
line and follow-up assessments, were considered to re-
flect improvement only if they were greater than the
minimal clinically important change (MCIC). The MCIC
for pain and disability has been established as 30% of
their baseline scores, with a minimum value of 1.5 for
VAS and 7 NDI points for neck pain-related disability
[19, 28]. This implied that it was impossible for patients
with baseline scores below these values, to show a clinic-
ally relevant improvement at follow-up.
For instance, it was impossible for a patient with a dis-
ability score smaller than the MCIC at baseline to ex-
perience improvement in disability, and including this
patient’s data into the model exploring factors associated
with a clinically relevant improvement in disability could
skew results. In the case of patients with baseline scores
below the MCIC, lack of improvement could only be
spotted if they experienced a worsening of pain or dis-
ability (i.e., an increase in the score at follow-up, as com-
pared to baseline). Therefore, in the case of patients
with a baseline score which was smaller than the MCIC
for a given variable, only those who at discharge had
shown to have experienced a worsening were included
in the analyses.
Outcome measures were neck pain, arm pain and dis-
ability. In order to quantify the likelihood that a given
patient would experience a clinically relevant improve-
ment in these variables, three separate multivariable
predictive logistic regression models were developed.
Improvement in NP, AP or disability were the
dependent variables, and the maximal models included:
gender; age (in years); baseline intensity of NP (VAS
points); baseline intensity of AP (VAS points); NP-
related disability at baseline (NDI percentage); duration
of the current episode in days (number of days); dur-
ation of the current episode (classified as acute or
chronic, with a cut-off limit at 90 days) [17]; time
elapsed since the first episode (years), employment status
(“working”, which was the reference category, “non
worker” or “receiving financial compensation for NP”);
diagnostic tests undertaken at any moment during the
study period (X-Rays, MRI, other); findings in imaging
procedures undertaken during the study period or previ-
ous episodes (disc degeneration, facet joint degeneration,
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scoliosis, spondylolisis, spinal stenosis, disc protrusion,
disc herniation, other findings, no findings); clinical
diagnosis (pain caused by disc protrusion/hernia, pain
caused by spinal stenosis, or non-specific, common neck
pain); and treatments used during the study period
(drugs -analgesics, NSAIDs, steroids, muscle relaxants,
opioids, other-, physiotherapy, rehabilitation, neuro-
reflexotherapy, surgery).
The value p > 0.05 was used to eliminate variables
from the model, following a non-automatic backward
strategy. Nomograms were developed to illustrate the re-
sults of the models [12].
The area under the ROC curve (AUC) was used to
asess discrimination of the final models, and calibration
was assessed using the Hosmer-Lemeshow test [12].
The selection of variables was validated by using boot-
strapping: 100 bootstrap samples were drawn [29]. Sam-
ple size was estimated using the number of observations
that contained no missing values [29, 30]. The variables
selected were displayed for each sample drawn, and the
total number of times each variable was selected was
counted [29].
Both the apparent performance of each bootstrap sam-
ple (“bootstrap performance”) and the performance of
the bootstrap model in the original sample (“test per-
formance”), were determined. Overfitting was defined as
the average difference between bootstrap performance
and test performance [31].
The Stata/IC v15.1(StataCorp, 2017) was used for stat-
istical analysis.
Results
All the 47 health care centers which were invited to par-
ticipate in this study, accepted. All patients invited to
participate in the study, agreed to sign the informed
consent. All were included and none were excluded.
Due to the multicenter design, when sample size was
reached, 3225 patients had been included. The second
assessment, which was planned 90 days after the first
one, generally took place later (median [p25;p75] = 103
[89;137] days), and 224 patients (6.95%) were lost to fol-
low up.
Among the 3001 patients who attended the follow-up,
most were women (74.2%), the median duration of their
pain episode was 180 days, and their baseline median
value for pain intensity was 6.6 VAS points for NP and
6.0 for AP, while their mean score for disability in the
NDI was 37.2 (Table 1). The baseline characteristics of
patients who were lost to follow up, were similar (data
not shown).
At baseline, 2961 patients reported some degree of NP
(i.e., VAS > 0), 2188 reported some degree of AP, and
1500 reported some degree of disability (i.e., NDI > 0).
Data from 6 patients were excluded from the regression
model on NP because their baseline scores were below
the threshold required for any potential improvement to
be “clinically relevant”. For the same reason, data from
105 and 49 patients were excluded from the regression
models on AP and disability, respectively. All the reasons
leading to the exclusion of data from the regression
models, are shown in Fig. 1.
Among the patients included in the corresponding
models, 1716 (72,3%) showed a clinically relevant im-
provement in NP at the 3 month assessment and the
remaining 656 did not, while 507 patients (51,6%)
showed a clinically relevant improvement in disability
and 476 did not (Table 2). Among the 1938 patients
who reported pain referred down to the arm (AP) when
entering the study, 1371(70.7%) showed a clinically rele-
vant improvement 3 months later, and 567 did not
(Table 2).Conversely, AP appeared during the study
period in 5 patients who had not reported it at baseline.
Among these patients, median (p25;p75) VAS score for
AP at the follow-up assessment was 3 (2;3).
The multivariable logistic regression model showed
that the factors which, at baseline, predicted a clinically
relevant improvement in NP 3 months later, were, from
highest to lowest frequency in bootstrapping validation
(Table 3a): being treated with neuro-reflexotherapy, pain
being acute (vs. chronic), arm pain being less severe,
working (vs. “receiving compensation assistance for NP”
or “non-worker”), not showing signs of disc degeneration
on imaging, suffering from “non-specific” pain (vs. pain
caused by spinal stenosis or disc herniation/protrusion),
being female, and suffering higher baseline intensity of
neck pain. The assessment of the calibration of the model
showed that the frequency of expected and observed prob-
abilities of improvement were similar (Hosmer-Lemeshow
test, p = 0.383). Discrimination of the model was good,
with an AUC of 0.718. Overfitting was 0.020.
Factors predicting a clinically relevant improvement in
AP 3 months later, were: being treated with neuro-
reflexotherapy, arm pain being more severe, pain being
acute (vs. chronic), not showing signs of disc degener-
ation on imaging, neck pain being less severe, and suffer-
ing from “non-specific” pain (vs. pain caused by spinal
stenosis or disc herniation/protrusion) (Table 3b). The
assessment of the calibration of the model showed that
the frequency of expected and observed probabilities of
improvement were similar (Hosmer-Lemeshow test, p =
0.369). Discrimination of the model was good, with an
AUC of 0.717. Overfitting was 0.030.
Factors predicting a clinically relevant improvement in
disability 3 months later, were: arm pain being less se-
vere, being treated with neuro-reflexotherapy, working
(vs. “receiving financial compensation for NP” or “non
worker”), baseline disability being higher, not showing
signs of facet joint degeneration on imaging, and pain
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being acute (vs. chronic) (Table 3c). The assessment of
the calibration of the model showed that the frequency
of expected and observed probabilities of improvement
were similar (Hosmer-Lemeshow test, p = 0.480). Dis-
crimination of the model was poor, with an AUC of
0.664. Overfitting was 0.037.
Figures 2, 3 and 4 show the nomograms corresponding
to the models on improvement of NP, AP and disability.
Discussion
Results from this study show that it is feasible to imple-
ment a registry for NP patients treated in routine clinical
practice. The registry included all patients seeking care
for NP in the participating centers, where they were
treated following standard practice in routine clinical
practice. Clinically relevant data were gathered using
previously validated methods [14, 16, 18, 24–26], and
the proportion of losses to follow-up was below 7%. Data
from this registry make it possible to develop predictive
models which are valid to determine the likelihood of
improvement, factoring in patients’ characteristics and
clinical decisions, and nomograms to facilitate the use of
these models in routine practice (Table 3, Figs. 2-4).
However, a registry analysis is an observational study,
and “association” does not necessarily imply “causality”.
Therefore, results showing the association between a
given variable and a better or worse prognosis should be
interpreted cautiously, taking clinical plausibility into ac-
count. For instance, the association between staying at
work and improvement in NP, which is consistent with
results from previous studies on NP [32, 33], might be
due to the fact that staying active improves the evolution
of NP, and/or to the fact that subjects staying at work
are those with a mental and personal attitude that are
conducive to a better prognosis.
Table 1 Characteristics of patients recruited, diagnostic tests
and treatments used during the study
Variables n = 3001
Gender (female)a 2227 (74.2)
Age (years)b 50.3 (16.0)
Employment statusa
Non worker 1166 (38.8)
Active 1453 (48.4)
Duration of the pain episode (days) c 180 (90; 365)
Duration of the pain episode categorized (days)a
Acute (< 90 days) 971 (32.4)
Chronic (≥90 days) 2030 (67.6)
Time elapsed since first episodea
< 1 year 648 (21.6)
1–5 years 984 (32.8)
5–10 years 677 (22.6)
> 10 years 572 (19.1)
Baseline intensity of neck pain (VAS)b, d 6.6 (2.2)
Baseline intensity of arm pain (VAS) b, e 6.0 (2.5)
Baseline disability (NDI) b f 37.2 (19.2)
Diagnostic procedures during the episodea
X-Ray 699 (23.3)
MRI 602 (20.1)
CT scan 40 (1.3)
EMG 58 (1.9)
Other 135 (4.5)
Imaging findingsa
Disc degeneration 1335 (44.5)
Facet joint degeneration 230 (7.7)
Scoliosis 135 (4.5)
Spinal stenosis 63 (2.1)
Disc protrusion 270 (9.0)
Disc herniation (extrusion) 518 (17.3)
Other imaging findings 388 (12.9)
No findings 995 (33.2)
Clinical diagnosis
Spinal stenosis 63 (2.1)
Disc herniation/protrusion 665 (22.2)
Nonspecific syndrome 2273 (75.7)
Treatmentsa
Analgesics 1959 (65.3)
NSAIDs 1826 (60.8)
Steroids 190 (6.3)
Muscle relaxants 736 (24.5)
Opioids 52 (1.7)
Other 673 (22.4)
Table 1 Characteristics of patients recruited, diagnostic tests
and treatments used during the study (Continued)
Variables n = 3001
Non pharmacological treatmentsa
Physical therapy 175 (5.8)
Rehabilitation 343 (11.4)
Neuro-reflexotherapy 2580 (86.0)
Surgery 8 (0.3)
Other treatmentsa
Rhizolysis 3 (0.1)
EpiduraI injections 13 (0.4)
Referral to pain unit 12 (0.4)
Other treatmentsg 31 (1.0)
a Frequency (%) b Mean (sd) c Median (p25;p75) d:Patient with VAS for NP > 0
(n = 2961)e:Patient with VAS for AP > 0 (n = 2188)f:Patient with NDI > 0 (n =
1500)g:Includes; ozone injections, spinal manipulation, acupuncture,
and homeopathy,
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Nevertheless, results from this study are in line with
those from previous studies and are clinically plausible;
most imaging findings are unlikely to predict the clinical
evolution of NP, AP or disability, unless there is a correl-
ation between clinical and radiological findings [34]; ra-
dicular pain caused by symptomatic spinal stenosis or disc
herniation is harder to treat than referred pain associated
with common NP; irrespective of the treatments applied
and other patient characteristics, chronic (vs. acute) pain
is associated with a worse prognosis for pain and disabil-
ity; neuro-reflexotherapy is associated with a significant
improvement in pain and disability [16, 24, 27]; staying at
work is associated with a better prognosis [32, 33]; and a
higher baseline value for a given variable (NP, AP or dis-
ability) leaves more room for its improvement, whereas
the prognosis is worse for patients who are more severely
affected (in terms of the other variables).
It is likely that the evolution of disability is affected by
additional variables which were not assessed in this
registry. In fact, discrimination was good in the models
on NP and AP, whereas it was poor in the model on dis-
ability. Additionally, baseline mean score for disability
was mild, and in a significant number of patients it was
below the value of the minimal clinically important
change. As a result, the model on disability only in-
cluded data from approximately 40% of the patients.
Despite all of the above, for all models discrimination
was > 0.663 and calibration was acceptable, which sug-
gests that nomograms may be applicable in clinical prac-
tice for early identification of patients who are at a
higher risk of becoming chronic.
Many different treatment modalities are used for
the treatment of NP, but very few are supported by
solid evidence on efficacy or effectiveness deriving
from high quality randomized controlled trials (RCTs)
[3, 16, 35–49]. In fact, few RCTs on spinal pain have
focused on NP [3], maybe because it is less prevalent than
low back pain [1, 2]. As a result, clinical practice in the NP
field is largely driven by the results from RCTs on other
pain conditions, mainly low back pain, and RCTs to assess
the efficacy, effectiveness and cost-effectiveness of treat-
ments for NP are suitable [3].
Registries cannot substitute RCTs, and are not valid
for proving the efficacy or effectiveness of treatments.
However, they can be useful to assess the prognostic
value of procedures which have previously shown to
be efficacious through appropriate randomized clinical
trials, or are assumed to be effective based on the evi-
dence on their effect in other types of spinal pain.
None of the pharmacological groups which were ana-
lyzed in this study was associated with clinical im-
provement. This might be due to the fact that, for
the treatment of patients with NP, drugs are essen-
tially designed to offer symptomatic pain relief, while
this study focused on the improvement of the pain
episode at 3 months. For the same reason, the time-
frame of this study may be inappropriate to capture
the effect of treatments aiming to prevent relapse or
requiring longer periods to have an effect, such as ex-
ercise or surgery.
Previous studies and systematic reviews on prognosis
factors for neck pain vary substantially in design and
Fig. 1 Flow chart showing the number of patients whose data were included in the regression models
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Table 2 Characteristics of patients in whom neck pain, arm pain and disability improved and did not improve
Variables Improvement of neckpain Improvement of armpain Improvement of disability
No (n = 656) Yes (n = 1716) No (n = 567) Yes (n = 1371) No (n = 476) Yes (n = 507)
Gender (female)a 505 (77.0) 1263 (73.6) 435 (76.7) 1053 (76.8) 345 (72.5) 360 (71.0)
Age (years)b 48.6 (17.9) 50.9 (15.3) 50.5 (15.7) 51.6 (14.4) 47.8 (18.7) 48.3 (16.2)
Employment statusa
Not applicable 374 (57.0) 695 (40.5) 267 (47.1) 457 (33.3) 314 (66.0) 269 (53.1)
Not working 67 (10.2) 101 (5.9) 50 (8.8) 77 (5.6) 57 (12.0) 49 (9.7)
Working 215 (32.8) 920 (53.6) 183 (32.3) 664 (48.4) 105 (22.1) 189 (37.3)
Duration of the pain episode (days) c 180 (60; 365) 180 (90; 365) 180 (90; 365) 240 (90; 365) 90 (32.5; 195) 120 (60; 365)
Duration of the pain episode categorized (days) a
Acute (< 90 days) 259 (39.5) 570 (33.2) 175 (30.9) 370 (27.0) 236 (49.6) 222 (43.8)
Chronic (≥90 days) 397 (60.5) 1146 (66.8) 392 (69.1) 1001 (73.0) 240 (50.4) 285 (56.2)
Time since first episode (years)a
< 1 168 (25.6) 339 (19.8) 110 (19.4) 245 (17.9) 146 (30.7) 144 (28.4)
1–5 242 (36.9) 571 (33.3) 209 (36.9) 470 (34.3) 179 (37.6) 169 (33.3)
5–10 125 (19.1) 409 (23.8) 125 (22.1) 336 (24.5) 80 (16.8) 90 (17.8)
> 10 98 (14.9) 346 (20.2) 102 (18.0) 278 (20.3) 55 (11.6) 73 (14.4)
Baseline intensity of neck pain (VAS)b 6.0 (2.4) 6.7 (2.2) 6.6 (2.1) 7.1 (1.9) 5.6 (2.3) 6.1 (2.3)
Baseline intensity of arm pain (VAS)b 5.5 (2.5) 6.1 (2.5) 5.6 (2.4) 6.5 (2.2) 5.3 (2.5) 5.4 (2.5)
Baseline disability (NDI)b 34.1 (20.5) 37.0 (18.6) 39.5 (20.0) 41.8 (16.5) 32.8 (19.0) 38.4 (18.4)
Diagnostic procedures during the episodea
X-Ray 122 (18.6) 457 (26.6) 118 (20.8) 348 (25.4) 80 (16.8) 101 (19.9)
MRI 115 (17.5) 364 (21.2) 109 (19.2) 285 (20.8) 65 (13.7) 110 (21.7)
CT scan 7 (1.1) 29 (1.7) 9 (1.6) 19 (1.4) 2 (0.4) 7 (1.4)
EMG 15 (2.3) 27 (1.6) 17 (3.0) 27 (2.0) 14 (2.9) 9 (1.8)
Other 36 (5.5) 71 (4.1) 39 (6.9) 60 (4.4) 29 (6.1) 19 (3.8)
Imaging findingsa
Disc degeneration 303 (46.2) 659 (38.4) 312 (55.0) 602 (43.9) 266 (55.9) 294 (58.0)
Facet joint degeneration 73 (11.1) 103 (6.0) 74 (13.1) 77 (5.6) 68 (14.3) 42 (8.3)
Scoliosis 25 (3.8) 75 (4.4) 24 (4.2) 61 (4.5) 21 (4.4) 28 (5.5)
Spinal stenosis 12 (1.8) 32 (1.9) 16 (2.8) 29 (2.1) 11 (2.3) 9 (1.8)
Disc protrusion 75 (11.4) 95 (5.5) 76 (13.4) 115 (8.4) 52 (10.9) 40 (7.9)
Disc herniation (extrusion) 112 (17.1) 234 (13.6) 123 (21.7) 245 (17.9) 79 (16.6) 117 (23.1)
Other findings 72 (11.0) 201 (11.7) 77 (13.6) 168 (12.3) 58 (12.2) 99 (19.5)
No findings 131 (20.0) 756 (44.1) 116 (20.5) 587 (42.8) 14 (2.9) 29 (5.7)
Clinical diagnosis
Spinal stenosis 12 (1.8) 32 (1.9) 16 (2.8) 29 (2.1) 11 (2.3) 9 (1.8)
Disc protrusión/Herniation 164 (25.0) 285 (16.6) 173 (30.5) 302 (22.0) 117 (24.6) 143 (28.2)
Nonspecific syndrome 480 (73.2) 1399 (81.5) 378 (66.7) 1040 (75.9) 348 (73.1) 355 (70.0)
Treatments
Analgesics 419 (63.9) 1139 (66.4) 391 (69.0) 959 (70.0) 339 (71.2) 353 (69.6)
NSAIDs 387 (59.0) 1062 (61.9) 352 (62.1) 888 (64.8) 310 (65.1) 347 (68.4)
Steroids 60 (9.2) 98 (5.7) 53 (11.1) 42 (8.3)
Muscle relaxants 170 (25.9) 438 (25.5) 147 (25.9) 347 (25.3) 142 (29.8) 170 (33.5)
Opioids 11 (1.7) 22 (1.3) 10 (1.8) 24 (1.8) 14 (2.9) 15 (3.0)
Kovacs et al. BMC Musculoskeletal Disorders          (2019) 20:620 Page 7 of 13
setting, and methodological shortcomings have led to
uncertainty about the reliability of the prognostic factors
which have been suggested [4]. In fact, many original
studies on prognostic factors are re-analyses of random-
ized controlled trials with relatively small samples, which
aim to identify subsets of patients who respond better to
some form of specific treatment [4]. This makes it in-
appropriate to compare their results with those from this
study, in which a large population recruited in routine
clinical practice and receiving a broad array of treat-
ments, was analyzed.
The representativeness of the sample does not ap-
pear to be a major concern; recruiting centers were
spread over 11 out of the 17 administrative regions
existing in Spain, they included state-owned (i.e.,
“public”) and private practices (both working for the
Spanish National Health Service and for private insti-
tutions, both for profit and non for profit), and they
included primary care, physical therapy and specialty
centers. All patients seeking care in these practices
were screened consecutively, all those who complied
with inclusion criteria were included, none were ex-
cluded, losses to follow-up were below 7%, and pa-
tients’ characteristics are in line with the typical
patient requesting care for neck pain (Table 1). How-
ever, since most spinal neck surgery in Spain is per-
formed at Neurosurgery Departments, and none
participated in this study, only 8 patients (0.3%)
underwent surgery, which makes this study unsuitable
to assess the potential predictive value of spinal neck
surgery on the evolution of a pain episode.
In fact, this study and the registry from which it
derives, have a number of limitations. At the design
phase of this study, it was decided that the sample
should represent patients seeking health care for
neck pain, reflecting prevalent (and not only inciden-
tal) cases. As a result, the sample included both
patients with acute pain and those with (exacerba-
tions of) chronic pain. The proportion of acute and
chronic patients might have been different if the pro-
portion of primary and specialty centers had been
different.
Should the study have been conducted in a different
setting, the proportion of patients receiving each form of
treatment might also have been different. In fact, this
study did not gather any data on the rationale for pre-
scribing a specific treatment to a given patient. There-
fore, such a rationale and how strictly the clinicians
involved in this study followed indication criteria for
each treatment, are unknown. However, this is usual in
routine practice, and this study did not aim to assess
the therapeutic effect of any treatments in experimental
conditions, but their prognostic value in routine prac-
tice. Moreover, this study included a broad array of pa-
tients, recruited in both primary and specialty care
centers, and the analysis made it possible to assess the
association between each one of their characteristics
and their prognosis for pain and disability. Future stud-
ies should explore the generalizability of these models
to other cultural contexts.
In Spain, especially within the Government run
health system (i.e., the National Health Service), pa-
tients are first seen by a primary care physician, who
acts as a “gatekeeper”, checks for the presence of “red
flags” and refers patients with indication criteria for a
specialized treatment to the appropriate specialist.
Therefore, some treatments are almost exclusively ap-
plied in Services specialized in that given treatment
(e.g., physical therapy, neuroreflexotherapy, rehabilita-
tion or orthopedic surgery). This implies that, in this
Table 2 Characteristics of patients in whom neck pain, arm pain and disability improved and did not improve (Continued)
Variables Improvement of neckpain Improvement of armpain Improvement of disability
No (n = 656) Yes (n = 1716) No (n = 567) Yes (n = 1371) No (n = 476) Yes (n = 507)
Other 145 (22.1) 362 (21.1) 143 (25.2) 290 (21.2) 148 (31.1) 182 (35.9)
Non pharmacological treatments
Physical therapy 38 (5.8) 100 (5.8) 33 (5.8) 72 (5.3) 24 (5.0) 28 (5.5)
Rehabilitation 84 (12.8) 172 (10.0) 76 (13.4) 164 (12.0) 74 (15.6) 64 (12.6)
Neuro-reflexotherapy 428 (65.2) 1574 (91.7) 419 (73.9) 1332 (97.2) 252 (52.9) 379 (74.8)
Surgery 3 (0.5) 3 (0.2) 2 (0.4) 3 (0.2) 1 (0.2) 0 (0.0)
Other treatments
Rhizolysis 1 (0.2) 2 (0.1) 1 (0.2) 2 (0.1) 2 (0.4) 1 (0.2)
Epidural injections 2 (0.3) 9 (0.5) 2 (0.4) 8 (0.6) 3 (0.6) 4 (0.8)
Referral to pain unit 7 (1.1) 4 (0.2) 7 (1.3) 4 (0.3) 9 (1.9) 2 (0.4)
Othertreatmentsd 3 (0.5) 17 (1.0) 5 (0.9) 11 (0.8) 4 (0.8) 7 (1.4)
aFrequency (%). b Mean (sd). c Median (p25;p75). d Includes; injections of ozone, spinal manipulation, acupuncture, and homeopathy
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Table 3 Predictive models for improvement
a. Predictive model for the improvement of neck pain (n = 2372).a,b
Variables Odds ratio p Frequency in bootstrapping validationc (100)
(I.C. 95%)
Being treated with neuro-reflexotherapy 9.90 (6.81; 14.38) < 0.001 100
Pain being chronic (≥ 90 days) 0.53 (0.41; 0.70) < 0.001 98
Baseline intensity of arm pain (VAS)d 0.93 (0.90; 0.97) < 0.001 95
Employment status (ref. working)
Non worker 0.87 (0.69; 1.10) 0.259 94
Receiving financial compensation for neck pain 0.48 (0.33; 0.69) < 0.001 94
Signs of disc degeneration on imaging 0.77 (0.62; 0.95) 0.017 68
Clinical diagnosis (ref. nonspecific pain)
Spinal stenosis 0.78 (0.39; 1.56) 0.482 63
Disc herniation/protusion 0.63 (0.49; 0.81) < 0.001 63
Female 0.77 (0.61; 0.97) 0.030 59
Baseline intensity of neck pain (VAS)d 1.06 (1.00; 1.13) 0.041 38
Constant 0.84 (0.60; 1.18) 0.325 –
b. Predictive model for the improvement of pain referred down into the arm (n = 1938).e,f
Variables Odds ratio p Frequency in bootstrapping validationg (100)
(I.C. 95%)
Being treated with neuro-reflexotherapy 16.96 (10.90; 26.37) < 0.001 100
Baseline intensity of arm pain (VAS) h 1.17 (1.10; 1.24) < 0.001 96
Pain being chronic (≥ 90 days) 0.57 (0.43; 0.75) < 0.001 84
Signs of disc degeneration on imaging 0.68 (0.54; 0.85) 0.001 83
Baseline intensity of neck pain (VAS)d 0.91 (0.85; 0.98) 0.010 73
Clinical diagnosis (ref. nonspecific pain)
Spinal stenosis 0.57 (0.52; 0.86) 0.088 56
Disc herniation/protrusion 0.67 (0.52; 0.86) 0.002 56
Constant 0.31 (0.19; 1.24) < 0.001 –
c. Predictive model for the improvement for disability (n = 983).i,j
Variables Odds ratio P Frequency in bootstrapping validationk (100)
(I.C. 95%)
Baseline intensity of arm pain (VAS)l 0.89 (0.85; 0.93) < 0.001 99
Being treated with neuro-reflexotherapy 2.92 (1.90; 4.49) < 0.001 97
Employment status (ref. working)
Non worker 0.69 (0.49; 0.97) 0.031 90
Receiving financial compensation for neck pain 0.45 (0.28; 0.73) 0.001 90
Baseline disability (NDI)m 1.02 (1.01; 1.02) 0.002 84
Signs of facet joint degeneration on imaging 0.60 (0.39; 0.93) 0.023 73
Pain being chronic (≥ 90 days) 0.65 (0.46; 0.91) 0.012 56
Constant 0.89 (0.59; 1.34) 0.589 –
aThe number of patients who reported some degree of pain referred down to the arm (AP) at baseline (VAS > 0), was 2961,6 had baseline scores below the cut-off for
considering potential improvements as “clinically relevant”, 583 had missing data at the baseline or the follow-up assessment, and 2372 were included in the model
bAUC = 0.718 (95%CI; 0.694–0.742). Hosmer-Lemeshow: chi2 = 0.383
cOverfitting = 0.020. Shrinkage factor = 0.906
dVAS: Visual Analog Scale (range from better to worse; 0–10)
eThe number of patients who reported some degree of neck pain (VAS > 0) at baseline, was 2961, 18 had baseline scores below the cut-off for considering potential
improvements as “clinically relevant”, 238 had missing data at the baseline or the follow-up assessment, and 2372 were included in the model
fAUC = 0.717 (95%CI; 0.691–0.742). Hosmer-Lemeshow: chi2 = 0.369
gOverfitting = 0.030. Shrinkage factor = 0.882
hVAS: Visual Analog Scale (range from better to worse; 0–10)
iThe number of patients who reported some degree of disability at baseline (NDI > 0), was 1500,49 had baseline scores below the cut-off for considering potential
improvements as “clinically relevant”, 468 had missing data at the baseline or the follow-up assessment, and 983 were included in the model
jAUC = 0.677 (95%CI; 0.644–0.711). Hosmer-Lemeshow: chi2 = 0.128
kOverfitting = 0.037. Shrinkage factor = 0.787
lVAS: Visual Analog Scale (range from better to worse; 0–10)
mScore on the Neck Disability Index (range from better to worse, 0–100)
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study, the prognostic value of being treated in one or
other Service could not be explored because multico-
linearity was detected between “treatment received”
and “specialty”. The prognostic value of the type of
clinician who treats the patient should be explored in
further studies, especially if conducted in settings
where patients with neck pain are the main decision
makers when deciding on the type of clinician they
chose to seek care from.
Losses to follow up beyond 3months in this register
are unknown and should be assessed in further studies.
This study focused on the clinical prognosis of a single
NP episode, and analyzing factors associated with re-
lapses was not within its scope and would require longer
follow-up periods.
The health care centers invited to join this study were
selected because of their previous involvement in re-
search on spinal pain, and are not a random sample of
health care centers. As a result, no neurosurgery practice
was included in the sample, and participating clinicians
may be more evidence-based in their practice than aver-
age, or more positively predisposed than average for
implementing a registry on NP. Nevertheless, these cen-
ters represented a feasible and adequate platform to test
run this registry in the context of routine practice, al-
though It may be more difficult to implement registries
in environments where the clinical community is less ac-
customed to e-health.
This registry did not include any psychological vari-
ables. This is due to the fact that, to date, the only
psychological variables potentially influencing the
prognosis of spinal pain which have been assessed in
the Spanish cultural setting are fear avoidance beliefs
and catastrophizing, and their influence has shown to
be clinically irrelevant or null [20, 21, 50]. Nonethe-
less, pain is known to be a sensory and emotional ex-
perience which may be affected by psychological
factors [51]. Therefore, psychological variables should
be added to this registry as soon as future research
identifies those with a prognostic value on neck pain
in this setting.
Conclusions
Results from this study suggest that the probability that
a patient with neck pain will experience improvements
in neck pain, arm pain and disability within a 3 months
period, can be quantified using the following data; base-
line scores for neck pain, arm pain and disability,
whether neck pain is acute or chronic, whether it is
“nonspecific” (vs. caused by disc herniation or spinal
stenosis), whether the patient is male or female, whether
he/she is treated with neuro-reflexotherapy, whether he/
she stays at work (vs. does not work or receives financial
compensation for neck pain), and whether he/she shows
some specific images on MRI.
Fig. 2 Nomogram for improvement of neck pain
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Fig. 3 Nomogram for improvement of arm pain
Fig. 4 Nomogram for improvement of disability
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